Stress News and Research

RSS

Cannabigerol shows promise in reducing anxiety and stress, study finds

Whether the phytocannabinoid cannabigerol impacted mood, stress, and anxiety and caused any related adverse effects of cognitive or motor impairment.

5 Aug 2024

University of Oxford’s online therapies offer hope for anxiety and PTSD patients

Urgent treatment solutions are needed for children, adolescents and adults with mental health conditions. Despite the government committing to spending 8.9% of all NHS funding on mental health treatment last year, the pipeline to build new facilities and train new staff will take years and, on their own, are insufficient to meet demand.

5 Aug 2024

Redefining global health regulation: Key steps for equitable access during emergencies

Three high-impact steps could be taken by global health leaders to reshape the global regulatory framework and help address the pressing need for equitable access to diagnostics, therapeutics, and vaccines during public health emergencies, say a Georgetown global health law expert and a medical student.

4 Aug 2024

Unraveling complex genetic and environmental landscape of schizophrenia

Patrick Sullivan, MD, FRANZCP, the Yeargan Distinguished Professor of Psychiatry and Genetics at the UNC School of Medicine, and researchers at the Karolinska Institutet in Stockholm, Sweden, have developed a comprehensive outline of the genetics of schizophrenia.

2 Aug 2024

Severe PTSD characterized by lower oxytocin and higher vasopressin levels

Research finds PTSD marked by reduced oxytocin and elevated vasopressin, suggesting AVP/OT ratios as potential biomarkers for diagnosis and treatment response.

1 Aug 2024

How states pioneered the medical marijuana movement in America

From the war on drugs to the current wave of legalization efforts, public opinion in the United States has shifted on few issues like it has with marijuana.

1 Aug 2024

Applying antifragility theory to cancer could revolutionize treatment methods

Researchers constantly seek innovative approaches to tackle cancer. One concept gaining traction is antifragility, a property where systems not only withstand stress but improve because of it.

1 Aug 2024

Study explores interplay between bone, adrenal glands, and aging

Figuring out how the tissues in our bones, adrenal glands, muscle and fat "talk" to each other could help scientists better understand what happens to our skeletons with age, when our bones tend to lose mass and become weaker, leaving us at risk for falls and fractures.

1 Aug 2024

Targeting 14 modifiable risk factors from childhood to old age could prevent or delay dementia

Addressing 14 modifiable risk factors, starting in childhood and continuing throughout life, could prevent or delay nearly half of dementia cases, even as people around the world live longer and the number of people with dementia is set to rise dramatically in all countries, according to the third Lancet Commission on dementia prevention, intervention, and care, which is being presented at the Alzheimer's Association International Conference (AAIC 2024).

1 Aug 2024

Anticancer drugs show promise in reducing Alzheimer's dementia risk

Study finds anticancer drugs, specifically antimetabolites and molecular targeted therapies, may reduce the risk of Alzheimer's type dementia but not vascular dementia.

1 Aug 2024

COVID-19 significantly increases risk of hearing loss in young adults, study finds

Young adults with COVID-19 face a significantly higher risk of hearing loss and sudden sensorineural hearing loss. Researchers urge awareness and further investigation into COVID-19-related auditory damage.

31 Jul 2024

FDA clears UAB startup's TIX100 for clinical trials

The University of Alabama at Birmingham startup TIXiMED, Inc., has obtained clearance from the United States Food and Drug Administration to proceed to clinical trials under an Investigational New Drug for TIX100, its novel oral Type 1 diabetes drug.

31 Jul 2024

Study finds cannabigerol effectively reduces anxiety, boosts memory recall

A lesser-known cannabinoid that is gaining in popularity Cannabigerol (CBG) effectively reduced anxiety in a clinical trial without the intoxication typically associated with whole plant cannabis.

31 Jul 2024

Neurodivergent children face higher risk of chronic disabling fatigue by 18, study finds

Neurodivergent traits in childhood double the risk of chronic disabling fatigue by age 18, with inflammation playing a significant mediating role. This highlights the importance of addressing inflammatory markers in managing the health of neurodivergent individuals.

31 Jul 2024

Vegan diet may slow aging

Vegan diets showed short-term benefits on epigenetic aging compared to omnivorous diets in healthy twins, with reduced epigenetic age metrics observed in the vegan group. However, telomere length and overall mitotic clock values remained unchanged for both diets.

31 Jul 2024

Older adults with diabetes faced elevated risk of depression during the COVID-19 pandemic

A recent study of more than 2,700 older Canadians reported older adults with diabetes faced a heightened risk of depression during the COVID-19 pandemic.

31 Jul 2024

Long-term mental health impacts of COVID-19 unequal in LA county

New evidence has emerged about the long-term effects of the COVID-19 pandemic in Los Angeles County, as shown by a recent study in the journal PLOS ONE. Scientists at USC and the Los Angeles County Department of Public Health (DPH) found that existing disparities in mental health between white and non-white residents worsened.

31 Jul 2024